Skip to content
Clinical Trials – home
SpainBack to Spain

Clinical trials in Vitoria – page 4

109 clinical trials in Vitoria, Spain across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

SpainOur site in SpainEnsayosClinicos.es(opens in a new tab)
Vitoria at a glance
109
clinical trials
  • Research sites3
Type of trial
Recruitment status
Quick filters

109 trials in Vitoria

Open in trial search

Colon cancer

Recruiting

Study on the Effectiveness of Neoadjuvant Chemotherapy with Oxaliplatin and Capecitabine for Patients with Locally Advanced Colon Cancer

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Clinica Universidad De Navarra

Study on Continuous vs. Intermittent Infusion of Ampicillin and Ceftriaxone for Patients with Enterococcus faecalis Infective Endocarditis

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Amoxicillin
  • Sponsor:Fundacion Para La Gestion De La Investigacion En Salud De Sevilla

Back pain

Recruiting

Study on the Use of Platelet Concentrate and Betamethasone for Treating Chronic Low Back Pain in Patients with Lumbar Disc Degeneration

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Platelet Concentrate
  • Sponsor:Biotechnology Institute I Mas D S.L.

Study on Long-Term Use of Infigratinib for Children with Achondroplasia

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:0–17 years
  • Substances:Infigratinib
  • Sponsor:Qed Therapeutics Inc.

Neoplasm

Recruiting

Study on the Safety of RP-6306 Alone or with RP-3500 or Debio 0123 for Patients with Advanced Solid Tumors

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Camonsertib
  • Sponsor:Debiopharm International S.A.

Study on the Effectiveness of Clopidogrel, Prasugrel, and Ticagrelor in Patients with Coronary Acute Syndrome Using VerifyNow Device

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Clopidogrel
  • Sponsor:Fundacion Epic

Study on the Safety and Effectiveness of TransCon CNP for Infants with Achondroplasia

Investigational
Countries:SpainSpain
  • Participants:0–17 years
  • Substances:Navepegritide
  • Sponsor:Ascendis Pharma Growth Disorders A/S

Study on Bladder Cancer: Testing Cisplatin and Drug Combination for Patients with Non-Muscle Invasive Bladder Cancer

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Cisplatin
  • Sponsor:Hospital Universitario La Paz

Study on the Effectiveness of Oxygen for Patients with Intermediate-Risk Acute Pulmonary Embolism

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Oxygen
  • Sponsor:Fundacion Para La Investigacion Biomedica Del Hospital Universitario Ramon Y Cajal

Study on the Effectiveness and Safety of Dapirolizumab Pegol for Patients with Moderate to Severe Systemic Lupus Erythematosus

Registered drug
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Anhydrous Caffeine
  • Sponsor:UCB Biopharma

Study on the Long-Term Safety of Dapirolizumab Pegol for Patients with Systemic Lupus Erythematosus

Registered drugNo placebo
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Anhydrous Caffeine
  • Sponsor:UCB Biopharma

Study on the Safety and Effectiveness of TransCon CNP for Children and Adolescents with Achondroplasia

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:0–17 years
  • Substances:Navepegritide
  • Sponsor:Ascendis Pharma Growth Disorders A/S

Other cities in Spain

The busiest research cities in the country

All 210 cities in Spain

Clinical research in Vitoria

What the registry says about research in the country

01 Oncology Research

Innovative trials focusing on breast cancer treatments, including studies of atezolizumab with chemotherapy and novel approaches for HER2-positive breast cancer. Additional research explores treatments for bladder cancer and pancreatic adenocarcinoma.

  • Triple-negative breast cancer therapy
  • Non-muscle invasive bladder cancer treatment
  • Metastatic cancer interventions

Researchers are evaluating both immunotherapy and targeted treatments to improve patient outcomes.

02 Autoimmune Disorders

Comprehensive studies examining treatments for Sjögren's Syndrome and systemic lupus erythematosus. Research includes evaluation of novel therapies like dazodalibep and efgartigimod for managing autoimmune conditions.

  • Primary Sjögren's Disease treatments
  • Lupus management strategies
  • Innovative biological therapies

Focus on long-term safety and efficacy of new therapeutic approaches.

03 Neurological Conditions

Studies investigating treatments for multiple sclerosis, narcolepsy, and idiopathic hypersomnia. Research includes evaluation of remibrutinib and novel sleep disorder therapies.

  • MS relapse reduction
  • Sleep disorder management
  • Neurological therapeutic advances

Emphasis on developing targeted treatments for better disease control.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.